Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab.
Takayoshi Komatsu-FujiiMotoo NomuraAtsushi OtsukaYoshihiro IshidaKeitaro DoiShigemi MatsumotoManabu MutoKenji KabashimaPublished in: The Journal of dermatology (2019)